Related Experiment Video
Updated: Dec 20, 2025

Production of Extracellular Matrix Fibers via Sacrificial Hollow Fiber Membrane Cell Culture
Published on: February 2, 2019
Prospective Multicenter Evaluation of an Advanced Extracellular Matrix for Wound Management
Rose Raizman1, Rosemary Hill, Kevin Woo
1Rose Raizman, RN-EC, NSWOC, MSc, is nurse practitioner and enterostomal therapist, Centenary Hospital, Toronto, Ontario, Canada. Rosemary Hill, RN, CWOCN, CETN(C), is Certified Wound Ostomy Continence Clinician, Lions Gate Hospital, North Vancouver, British Columbia; Kevin Woo, PhD, RN, NSWOC, WOCC(C), FAPWCA, is Associate Professor, Queens University, Kingston, Ontario. Acknowledgments: Aroa Biosurgery Limited (New Zealand) provided study products, editorial assistance, and travel grants for conference attendance to the authors. Endoform is currently available in the following countries: New Zealand, Canada, US, Germany, Thailand, Jordan, and Mexico. The authors have disclosed no other financial relationships related to this article. Submitted December 20, 2019; accepted in revised form February 19, 2020.
Objective:
To evaluate an advanced extracellular matrix made of ovine forestomach matrix (OFM) for healing a variety of wound types.
Methods:
Participants were enrolled from inpatient, outpatient, and home healthcare settings. The OFM was used to treat all wounds and applied to the wound bed every 3 to 7 days until closure.
Results:
Researchers enrolled 29 participants with 33 wounds. Average time to wound closure was 8.2 weeks, the percentage of wounds that reduced in size by 50% or more at 4 weeks was 64%, the average wound area reduction at 4 weeks was 66%, and 73% of wounds had closed at 12 weeks. No adverse effects were observed.
Conclusions:
This represents the first Canadian evaluation of OFM for the treatment of wounds, and the positive healing outcomes observed could support more widespread adoption of this matrix.
More Related Videos
09:17Optimizing Extracellular Vesicle Delivery Using a Core-Sheath 3D-Bioprinted Scaffold for Chronic Wound Management
Published on: February 28, 2025
08:41Processing of Human Cardiac Tissue Toward Extracellular Matrix Self-assembling Hydrogel for In Vitro and In Vivo Applications
Published on: December 4, 2017